se of transthoracic echocardiography with agitated saline injection to detect transpulmonary shunting and Hepatopulmonary Syndrome in patients with advanced liver disease awaiting liver transplantatio

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)0 sites0 target enrollmentSeptember 30, 2005

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Not specified
Sponsor: Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

September 30, 2005

End Date

TBD

Last Updated

11 years ago

Study Type

Interventional

Investigators

Sponsor

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

•Current inclusion criteria as of 19/09/2007:
•1\. Potential research participants will be identified prospectively from all those admitted electively for transplant assessment to the University Hospital Birmingham over a one year period
•2\. They will be approached on the morning of admission to hospital. They will be given a patient information leaflet and have an opportunity to ask questions. Consent will not be taken at this time
•3\. Echocardiograms for pre\-transplant assessment are performed on a Monday afternoon. Before the start of the test potential research participants will be approached and given an opportunity to ask further questions. At their satisfaction, they will be asked to sign a consent form if willing to participate
•4\. Patients electively admitted to UHB Liver Unit for assessment as to suitability for liver transplantation
•Previous inclusion criteria:
•Potential research participants will be all patients electively admitted to the Liver Transplantation Programme of the University Hospital Birmingham over a 6 month period from 01/10/2004 for pretransplant assessment. Prospective participants will be identified by review of elective admission lists, and will be approached by one of the investigators (RS) on the morning of admission to hospital. At this time they will be given the relevant information sheet and have an opportunity to ask questions. Consent will not be taken at this time.
•The echocardiograms are performed later that day, and before the test patients will again have the opportunity to ask questions. The consent form will then be signed at this time if the patient is willing to participate.